NO20005724L - Biologisk aktiv sammensetning - Google Patents

Biologisk aktiv sammensetning

Info

Publication number
NO20005724L
NO20005724L NO20005724A NO20005724A NO20005724L NO 20005724 L NO20005724 L NO 20005724L NO 20005724 A NO20005724 A NO 20005724A NO 20005724 A NO20005724 A NO 20005724A NO 20005724 L NO20005724 L NO 20005724L
Authority
NO
Norway
Prior art keywords
biologically active
active agent
carrier
active composition
chemical reaction
Prior art date
Application number
NO20005724A
Other languages
English (en)
Other versions
NO20005724D0 (no
Inventor
Aake Lindahl
Haakan Hagslaett
Catharina Benediktsson
Rickard Bryland
Original Assignee
Bioglan Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioglan Ab filed Critical Bioglan Ab
Publication of NO20005724D0 publication Critical patent/NO20005724D0/no
Publication of NO20005724L publication Critical patent/NO20005724L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Abstract

Oppfinnelsen angår en ny biologisk aktiv sammensetning som innbefatter et biologisk aktivt middel som skal frigis derfra, hvor nevnte biologisk aktive middel er oppløst og/eller dispergert i en overmettet tilstand innenfor en bærer, hvorved bæreren innbefatter en flytende og/eller fast ikke-krystallinsk ester og/eller polyestermatriks og hvor presipitering av nevnte biologisk aktive middel er i det vesentlige, eller fullstendig, inhibert deri. Nevnte overmettede tilstand kan oppnås ved å utsette en eller flere bærerstartsubstans(er) for slike kjemiske reaksjon(er) at det tilveiebringes en ester og/eller polyestermatriks, hvor det biologisk aktive middelet tilsettes etter nevnte - kjemiske reaksjon(er), har blitt avsluttet.
NO20005724A 1998-05-14 2000-11-13 Biologisk aktiv sammensetning NO20005724L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801704A SE9801704D0 (sv) 1998-05-14 1998-05-14 Biologically active composition
PCT/SE1999/000823 WO1999058108A1 (en) 1998-05-14 1999-05-12 Biologically active composition

Publications (2)

Publication Number Publication Date
NO20005724D0 NO20005724D0 (no) 2000-11-13
NO20005724L true NO20005724L (no) 2001-01-09

Family

ID=20411318

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005724A NO20005724L (no) 1998-05-14 2000-11-13 Biologisk aktiv sammensetning

Country Status (20)

Country Link
US (1) US6537576B1 (no)
EP (1) EP1082102B1 (no)
JP (1) JP2002514587A (no)
KR (1) KR100592971B1 (no)
CN (1) CN1309553A (no)
AT (1) ATE310500T1 (no)
AU (1) AU736480B2 (no)
CA (1) CA2331527C (no)
DE (2) DE1082102T1 (no)
ES (1) ES2155048T3 (no)
GR (1) GR20010300013T1 (no)
HU (1) HUP0102426A2 (no)
IL (2) IL139576A0 (no)
NO (1) NO20005724L (no)
NZ (1) NZ508073A (no)
PL (1) PL344051A1 (no)
SE (1) SE9801704D0 (no)
TR (1) TR200003589T2 (no)
WO (1) WO1999058108A1 (no)
ZA (1) ZA200006474B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1280485A4 (en) * 2000-02-29 2006-11-29 Zars Inc TRANSDERMAL STAMP FOR IMPROVED MEDICINE
KR20090031726A (ko) * 2006-06-14 2009-03-27 닥터 레디스 레보러터리즈 리미티드 국소용 조성물
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
EP2349230A2 (en) 2008-10-06 2011-08-03 Mylan Technologies, Inc. Amorphous rotigotine transdermal system
WO2014134510A1 (en) 2013-02-28 2014-09-04 Dermira, Inc. Glycopyrrolate salts
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD217989A1 (de) 1983-08-09 1985-01-30 Univ Ernst Moritz Arndt Verfahren zur herstellung einer pharmazeutischen zubereitung
US4940701A (en) 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
AR246186A1 (es) 1989-11-17 1994-07-29 Beta Pharm Co Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
SE9502244D0 (sv) * 1995-06-20 1995-06-20 Bioglan Ab A composition and a process for the preparation thereof
US5906830A (en) 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
GB2306885B (en) * 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions

Also Published As

Publication number Publication date
ATE310500T1 (de) 2005-12-15
HUP0102426A2 (hu) 2002-03-28
ES2155048T1 (es) 2001-05-01
US6537576B1 (en) 2003-03-25
KR100592971B1 (ko) 2006-06-23
SE9801704D0 (sv) 1998-05-14
DE69928524D1 (de) 2005-12-29
IL139576A0 (en) 2002-02-10
IL139576A (en) 2007-07-04
AU736480B2 (en) 2001-07-26
ZA200006474B (en) 2001-09-04
NZ508073A (en) 2002-12-20
AU4405099A (en) 1999-11-29
CA2331527C (en) 2010-04-13
JP2002514587A (ja) 2002-05-21
ES2155048T3 (es) 2006-06-16
DE1082102T1 (de) 2001-09-06
EP1082102B1 (en) 2005-11-23
CN1309553A (zh) 2001-08-22
PL344051A1 (en) 2001-09-24
GR20010300013T1 (en) 2001-04-30
CA2331527A1 (en) 1999-11-18
WO1999058108A1 (en) 1999-11-18
EP1082102A1 (en) 2001-03-14
TR200003589T2 (tr) 2001-03-21
KR20010052348A (ko) 2001-06-25
DE69928524T2 (de) 2006-08-10
NO20005724D0 (no) 2000-11-13

Similar Documents

Publication Publication Date Title
Pommier et al. The formation and resealing of intercalator-induced DNA strand breaks in isolated L1210 cell nuclei
NO20005724L (no) Biologisk aktiv sammensetning
Patil et al. Sucrose diacrylate: a unique chemically and biologically degradable crosslinker for polymeric hydrogels
TR200200822T2 (tr) Uçucu bileşiklerin sıvı solüsyon içindeki katı maddelerden çıkarılması süreci
BR0109265A (pt) Processo para a obtenção de polihidroxialcanoatos (pha) ou seus copolìmeros e utilização de agentes de redução
BRPI0514743A (pt) métodos de isolamento de 1, 3-propanodiol e de 1, 2-propanodiol
NO20005725L (no) Biologisk aktiv sammensetning
EP0331745A4 (en) Ferrocene derivatives, surfactants containing same, and process for producing thin organic film
KR960706520A (ko) 거대단량체 제조
DE19634122A1 (de) Neuartige Bäder zur Erzeugung von Mikrostrukturen
Quastel The mechanism of bacterial action
BR9915484A (pt) Processo para o isolamento contìnuo de proteìnas ativas
TW200506531A (en) Photoresist composition for deep uv and process thereof
BR9807726A (pt) Processo para a preparação de um composto
Schaltegger et al. Dithranol: Further Investigations on the Structure-Activity-Relationship: The New Series of the 10-Mono-Alkyldithranol Derivatives
JPS60243165A (ja) 一時的保護被膜及びその製造方法
JPS52105282A (en) Immobilization of enzyme
Martin Chemoenzymatic synthesis, characterization and thermodynamic behavior of sugar-containing poly (acrylate) hydrogels
Piccardi et al. Application of a polarographic method for the determination of metals in sewage water).
KR890014025A (ko) 핵용출 화분의 제조방법
ATE309340T1 (de) Behandlung von zellen
TH19853B (th) ระบบยับยั้งสีย้อมไม่ให้ตกที่มีระบบตัวเร่งเพอร์ออกซิเดส
DE3427888A1 (de) Verfahren zur immobilisierung von biologischem material
KR940014181A (ko) 페수처리 미생물제의 제조방법
GB2404441A (en) Assay methods relating to the action of geminin in the licensing of dna replication complexes in transformed cells

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application